Karimah S. Bell Lynum, PharmD, MBA, BCPP

Aripiprazole Once-Monthly for the Treatment of Adult Patients in the Earlier Stages of Bipolar I Disorder – a Post Hoc Analysis of Data From a Double-Blind, Placebo-Controlled, 52-Week Randomized Withdrawal Trial

This post hoc analysis of data from a double-blind, placebo-controlled, 52-week randomized-withdrawal trial (NCT01567527) was conducted to evaluate the efficacy of aripiprazole once-month...

Karimah S. Bell Lynum , PharmD, MBA, BCPP;

10/26/2023

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

Karimah S. Bell Lynum, PharmD, MBA, BCPP

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products